A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding

Jodie N Painter , Susanne Kaufmann , Tracy A O’mara , Kristine M Hillman
Human Molecular Genetics 98 ( 6) 1159 -69

34
2016
Long-range regulators of the lncRNA HOTAIR enhanceits prognostic potential in breast cancer

Kenneth P. Nephew , Michael J.G. Milevskiy , Fares Al-Ejeh , Dennis H. Dowhan
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation

60
2016
Regulation ofBRCA1messenger RNA stability in human epithelial cell lines and during cell cycle progression

Jodi M. Saunus , Stacey L. Edwards , Juliet D. French , Chanel E. Smart
FEBS Letters 581 ( 18) 3435 -3442

9
2007
Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability

Paul K. Lovelock , Ee Ming Wong , Carl N. Sprung , Anna Marsh
Breast Cancer Research and Treatment 104 ( 3) 257 -266

8
2007
Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

Chanel E. Smart , Catherine Clarke , Kelly M. Brooks , Ashwini Raghavendra
Breast Cancer Research and Treatment 112 ( 2) 237 -241

6
2008
Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1

Christopher A. Pettigrew , Juliet D. French , Jodi M. Saunus , Stacey L. Edwards
Breast Cancer Research and Treatment 119 ( 1) 239 -247

10
2010
10
2012
Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

Jodi M. Saunus , Juliet D. French , Stacey L. Edwards , Dianne J. Beveridge
Cancer Research 68 ( 22) 9469 -9478

36
2008
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage

Joshua A. Betts , Mahdi Moradi Marjaneh , Fares Al-Ejeh , Yi Chieh Lim
American Journal of Human Genetics 101 ( 2) 255 -266

39
2017
eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.

Jonathan Beesley , Haran Sivakumaran , Mahdi Moradi Marjaneh , Wei Shi
American Journal of Human Genetics 107 ( 4) 778 -787

23
2020
Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR‐103 target site

Brooke L. Brewster , Francesca Rossiello , Juliet D. French , Stacey L. Edwards
Human Mutation 33 ( 12) 1665 -1675

41
2012
Allelic imbalance in human breast cancer

Juliet D. French , Stacey L. Edwards
Oncotarget 8 ( 7) 10763 -10764

2
2017
Chromatin interactome mapping at 139 independent breast cancer risk signals.

Jonathan Beesley , Haran Sivakumaran , Mahdi Moradi Marjaneh , Luize G. Lima
Genome Biology 21 ( 1) 8

25
2020
Non-coding RNAs underlie genetic predisposition to breast cancer

Mahdi Moradi Marjaneh , Jonathan Beesley , Tracy A. O’Mara , Pamela Mukhopadhyay
Genome Biology 21 ( 1) 7

6
2020
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.

Matt Trau , John F. Forbes , Rodney J. Scott , Melissa A. Brown
Nature Communications 6 ( 1) 5899 -5899

106
2015
Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.

Juliet D. French , Jasmyn Dunn , Chanel E. Smart , Nathan Manning
Genes, Chromosomes and Cancer 45 ( 3) 277 -289

38
2006
Long‐range transcriptional regulation of breast cancer genes

Joshua A. Betts , Juliet D. French , Melissa A. Brown , Stacey L. Edwards
Genes, Chromosomes and Cancer 52 ( 2) 113 -125

6
2013
Genetic determinants of breast cancer risk

Juliet D. French , Stacey L. Edwards
Current Opinion in Endocrine and Metabolic Research 15 1 -7

2020
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase

Hong You , Johannes U. Mayer , Rebecca L Johnston , Haran Sivakumaran
bioRxiv

1
2020
Functional dissection of breast cancer risk-associated TERT promoter variants

Sonja Helbig , Leesa Wockner , Annick Bouendeu , Ursula Hille-Betz
Oncotarget 8 ( 40) 67203 -67217

8
2017